Research
Hormonal
Lifestyle modifications can mitigate cancer risk associated with obesity.
Encouraging lifestyle changes can be a key strategy in cancer prevention efforts.
StrongSupportsmedium confidence
We highlight the critical importance of lifestyle modifications in obesity management and cancer risk mitigation.
Why this rating
The review synthesizes data from both animal and clinical studies.
Source
The Complex Connection between Obesity and Cancer: Signaling Pathways and Therapeutic Implications
Mohamed El‐Tanani et al. · Nutrition and Cancer · 2024
DOI 10.1080/01635581.2024.2361964
reviewCited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →